Report Highlights Successful Strategies for Creating and Maintaining an Effective Thought Leader Management System for Pharmaceutical Companies

Saturday, June 11, 2016 Corporate News J E 4

CHAPEL HILL, N.C., June 10, 2016 /PRNewswire/ -- Medical affairs leaders in the pharmaceutical industry agreed in a recent study that clinical research support and clinical advisory boards were the most important Key Opinion Leader services a pharma company can provide. New products are the lifeblood of a biopharmaceutical company and thus it stands to reason that seven in 10 study participants highly value Key Opinion Leader (KOL) services around designing and conducting clinical trials.

As therapeutic areas become more crowded, the effectiveness of a pharmaceutical company's thought leader management system has never been more important.

To create and maintain lasting and mutually beneficial relationships with thought leaders, organizations use systems, processes, and procedures to manage these important and complex relationships. To probe current trends and future directions in integrated thought leader management, research and consulting leader Best Practices, LLC conducted a new benchmarking study, "Creating and Maintaining a Strategic KOL Management and Engagement System."

Study objectives were to:

  • Identify the most common and favored organizational structure for strategic TL management and engagement
  • Understand the current state of TL management practices in the pharmaceutical industry
  • Determine how TL management practices are evolving
  • Identify innovative practices that are driving TL management success at other organizations

The study will help leaders involved in KOL management understand the current state of KOL management practices in the pharmaceutical industry, determine how TL management practices are evolving and identify innovative practices that are driving TL management success at other organizations.

The report is based on data from 34 thought-leader management leaders from 29 biopharma and device organizations who participated in a field survey. Four high-level participants were interviewed to add qualitative depth to the study.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link:

For related research, visit our Best Practices, LLC Web site at 

ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


To view the original version on PR Newswire, visit:

SOURCE Best Practices, LLC



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Veracyte Statement on CMS's Preliminary Gapfill Ra...
3M Canada Funds Personalized Medicine at London's ...